Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Payables (2016 - 2022)

Historic Payables for Avadel Pharmaceuticals (AVDL) over the last 14 years, with Q3 2022 value amounting to $2.5 million.

  • Avadel Pharmaceuticals' Payables fell 6393.66% to $2.5 million in Q3 2022 from the same period last year, while for Sep 2022 it was $2.5 million, marking a year-over-year decrease of 6393.66%. This contributed to the annual value of $7.7 million for FY2021, which is 16172.46% up from last year.
  • Avadel Pharmaceuticals' Payables amounted to $2.5 million in Q3 2022, which was down 6393.66% from $7.3 million recorded in Q2 2022.
  • In the past 5 years, Avadel Pharmaceuticals' Payables registered a high of $15.9 million during Q1 2018, and its lowest value of $2.5 million during Q3 2022.
  • Over the past 5 years, Avadel Pharmaceuticals' median Payables value was $5.1 million (recorded in 2021), while the average stood at $6.1 million.
  • In the last 5 years, Avadel Pharmaceuticals' Payables crashed by 7390.92% in 2019 and then surged by 16172.46% in 2021.
  • Quarter analysis of 5 years shows Avadel Pharmaceuticals' Payables stood at $3.5 million in 2018, then skyrocketed by 74.14% to $6.1 million in 2019, then plummeted by 51.9% to $2.9 million in 2020, then soared by 161.72% to $7.7 million in 2021, then plummeted by 67.72% to $2.5 million in 2022.
  • Its Payables stands at $2.5 million for Q3 2022, versus $7.3 million for Q2 2022 and $6.0 million for Q1 2022.